Showing results (161-170 of 432) with videos related to

Sort By:
Pageof 44
Cancer Cell|October 3, 2003
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancerShunyou Wang, Jing Gao, Qunying Lei, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2012
Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trialElahe A Mostaghel, Daniel W Lin, John K Amory, et al.
Plos One|October 8, 2013
A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumorsXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
The American Journal of Pathology|August 7, 2002
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49Lawrence D True, Kent Buhler, Janna Quinn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2007
Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissuesDaniel W Lin, Marian L Neuhouser, Jeannette M Schenk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot StudyRong Rong Huang, Chunlai Zuo, Christine E Mona, et al.
Oncotarget|November 16, 2017
PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesMilan S Geybels, Min Fang, Jonathan L Wright, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Molecular Cancer Research : MCR|March 16, 2013
PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortalityEric G Bluemn, Elysia Sophie Spencer, Brigham Mecham, et al.
The Prostate|June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic CounselingHeather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
Pageof 44